In Bahrain, the Pharmaceutical Products Regulation Department (PPR) of the National Health Regulatory Authority (NHRA) ensures in so far as possible, in consistent with current medical and scientific knowledge, the quality, safety and efficacy of pharmaceutical products, including medicines, health products, and alternative/complementary medicines in the Kingdom of Bahrain.
Before a pharmaceutical product can be sold in Bahrain, an application must be made to the NHRA and this must contain all of the necessary data supporting its quality, safety and efficacy, based on the current guidelines and procedures. PPR members review the scientific aspects of each application and reach a conclusion on the likely balance of any benefits versus risk before arriving at a decision.
- New license application for Bahrainis
- License Transfer
- License Re-Categorization
- New license application for Non-Bahrainis
- License Renewal
- License Examination
- Gap of practicen
- Visiting Physicians
- Good standing certificate